Cover Image
市場調查報告書

生物學心臟瓣膜的全球市場:醫療設備的開發平台評估

Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 365829
出版日期 內容資訊 英文 118 Pages
訂單完成後即時交付
價格
Back to Top
生物學心臟瓣膜的全球市場:醫療設備的開發平台評估 Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月08日 內容資訊: 英文 118 Pages
簡介

本報告提供全球生物學心臟瓣膜的市場上,的主要開發中產品與其臨床實驗的進展調查,產品的功能、特性比較分析 (臨床實驗的各進展階段) ,再加上主要企業簡介及代表性產品,近來的市場動靜 (業績報告、資本交易趨勢等) 的資訊彙整,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 生物學心臟瓣膜概要

第3章 臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 生物學心臟瓣膜的企業:各臨床實驗階段的開發中產品
  • 生物學心臟瓣膜:各臨床實驗階段的開發中產品

第5章 生物學心臟瓣膜市場:企業、產品概要

  • Children's Hospital Boston
    • 開發中產品及進行中的臨床實驗概要
  • Colibri Heart Valve, LLC
  • CorMatrix Cardiovascular, Inc.
  • CryoLife, Inc.
  • Cytograft Tissue Engineering, Inc.
  • Edwards Lifesciences Corporation
  • LivaNova PLC
  • Medtronic plc
  • Revivicor, Inc.
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stellenbosch University
  • Tendyne Medical, Inc.
  • Tissue Regenix Ltd
  • University of California, Irvine
  • University of Cambridge
  • University of Minnesota
  • ValveXchange, Inc. (Inactive)
  • VueKlar Cardiovascular Ltd.

第6章 生物學心臟瓣膜市場:目前的趨勢 (共24件)

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0439EPD

GlobalData's Medical Devices sector report, "Tissue Heart Valves - Medical Devices Pipeline Assessment, 2017" provides an overview of Tissue Heart Valves currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Heart Valves pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Heart Valves under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Heart Valves and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Heart Valves under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 4
  • 1.2 List of Figures 6

2 Introduction 7

  • 2.1 Tissue Heart Valves Overview 7

3 Products under Development 8

  • 3.1 Tissue Heart Valves - Pipeline Products by Stage of Development 8
  • 3.2 Tissue Heart Valves - Pipeline Products by Segment 9
  • 3.3 Tissue Heart Valves - Pipeline Products by Territory 10
  • 3.4 Tissue Heart Valves - Pipeline Products by Regulatory Path 11
  • 3.5 Tissue Heart Valves - Pipeline Products by Estimated Approval Date 12
  • 3.6 Tissue Heart Valves - Ongoing Clinical Trials 13

4 Tissue Heart Valves - Pipeline Products under Development by Companies 14

  • 4.1 Tissue Heart Valves Companies - Pipeline Products by Stage of Development 14
  • 4.2 Tissue Heart Valves - Pipeline Products by Stage of Development 15

5 Tissue Heart Valves Companies and Product Overview 16

  • 5.1 Abbott Vascular Inc Company Overview 16
    • 5.1.1 Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • 5.2 Children's Hospital Boston Company Overview 19
    • 5.2.1 Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 19
  • 5.3 Colibri Heart Valve, LLC Company Overview 20
    • 5.3.1 Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
  • 5.4 CorMatrix Cardiovascular Inc Company Overview 22
    • 5.4.1 CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • 5.5 CryoLife Inc Company Overview 28
    • 5.5.1 CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.6 Cytograft Tissue Engineering Inc (Inactive) Company Overview 30
    • 5.6.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
  • 5.7 Daidalos Solutions BV Company Overview 31
    • 5.7.1 Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.8 Edwards Lifesciences Corp Company Overview 34
    • 5.8.1 Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.9 Medtronic plc Company Overview 42
    • 5.9.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 42
  • 5.10 Revivicor Inc Company Overview 46
    • 5.10.1 Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.11 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 47
    • 5.11.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.12 Stellenbosch University Company Overview 48
    • 5.12.1 Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.13 Tissue Regenix Ltd Company Overview 49
    • 5.13.1 Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.14 University of California Irvine Company Overview 52
    • 5.14.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 52
  • 5.15 University of Cambridge Company Overview 54
    • 5.15.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.16 University of Minnesota Company Overview 55
    • 5.16.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.17 ValveXchange, Inc. (Inactive) Company Overview 56
    • 5.17.1 ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.18 VueKlar Cardiovascular Ltd Company Overview 59
    • 5.18.1 VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 59

6 Tissue Heart Valves- Recent Developments 60

  • 6.1 Aug 23, 2017: OmniGuide Appoints Ajay Bhave as its Chief Technology Officer 60
  • 6.2 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 60
  • 6.3 Aug 09, 2017: LivaNova Reports Second Quarter 2017 Results 63
  • 6.4 Aug 04, 2017: LivaNovas Perceval Sutureless Aortic Heart Valve Awarded New Technology Add-on Payment from the Center for Medicare and Medicaid Services 64
  • 6.5 Aug 02, 2017: Medtronic Expands Heart Valve Portfolio with FDA Approval and CE Mark of the Avalus Surgical Aortic Valve 65
  • 6.6 Jul 24, 2017: CryoLife Reports Second Quarter 2017 Financial Results 65
  • 6.7 Jul 05, 2017: Edward's INSPIRIS RESILIA Valve Receives FDA Approval 67
  • 6.8 Jun 12, 2017: LivaNova Appoints Keyna Skeffington as Senior Vice President and General Counsel 68
  • 6.9 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 68
  • 6.10 May 16, 2017: LivaNova Announces Thad Huston as Chief Financial Officer 71
  • 6.11 May 04, 2017: LivaNova Announces New Data Reaffirming Value of Perceval for Aortic Valve Replacement in Aortic Stenosis Patients 71
  • 6.12 May 03, 2017: LivaNova Reports First Quarter 2017 Results 73
  • 6.13 Apr 28, 2017: LivaNova to Unveil New Data Further Demonstrating the Perceval Sutureless Valve is a Safe and Effective Aortic Valve Replacement for Patients 74
  • 6.14 Apr 26, 2017: CryoLife Reports First Quarter 2017 Financial Results 75
  • 6.15 Apr 25, 2017: Edwards Lifesciences Reports First Quarter Results 76
  • 6.16 Mar 31, 2017: LivaNova Announces Chief Financial Officer Resignation 77
  • 6.17 Mar 31, 2017: LivaNova Reiterates Full-Year 2017 Guidance 78
  • 6.18 Mar 14, 2017: Medtronic Melody Transcatheter Pulmonary Valve First of Its Kind to Receive FDA Approval for Implantation in Failed Surgical Pulmonary Heart Valves 78
  • 6.19 Mar 01, 2017: LivaNova Reports Fourth Quarter and Full-Year 2016 Results 79
  • 6.20 Feb 23, 2017: LivaNova Announces Its Intent to Delist from London Stock Exchange 81
  • 6.21 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 81
  • 6.22 Feb 15, 2017: CryoLife Reports Fourth Quarter and Full Year 2016 Financial Results 84
  • 6.23 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 85
  • 6.24 Feb 01, 2017: Edwards Lifesciences Reports Fourth Quarter Results 86
  • 6.25 Jan 27, 2017: New Data Reinforce the Clinical Value of the Perceval Sutureless Valve as a Safe and Effective Bioprosthesis for Patients in Need of Aortic Valve Replacement 87
  • 6.26 Dec 08, 2016: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference 88
  • 6.27 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 90
  • 6.28 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 92
  • 6.29 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 93
  • 6.30 Nov 02, 2016: LivaNova Announces CEO Transition: Damien McDonald to Succeed Andre-Michel Ballester 94
  • 6.31 Nov 02, 2016: LivaNova Reports Third Quarter 2016 Results 94
  • 6.32 Nov 01, 2016: Early And Sustained Quality Of Life Improvements Seen For Intermediate Risk Patients Treated With Edwards Transcatheter Valves 96
  • 6.33 Oct 31, 2016: EDWARDS INTUITY Elite Rapid Deployment Valve Approved In Canada 96
  • 6.34 Oct 26, 2016: CryoLife Reports Third Quarter 2016 Financial Results 97
  • 6.35 Oct 25, 2016: James W. Bullock Joins CryoLife Board of Directors 98
  • 6.36 Oct 25, 2016: Edwards Lifesciences Reports Third Quarter Results 98
  • 6.37 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results 100
  • 6.38 Oct 03, 2016: Medtronic Avalus Surgical Aortic Valve Shows Positive Outcomes in One-Year Clinical Trial Results 101
  • 6.39 Sep 29, 2016: Edwards INSPIRIS RESILIA Valve Receives CE Mark 102
  • 6.40 Sep 29, 2016: LivaNova Announces Half-Year Financial Report 103
  • 6.41 Sep 28, 2016: Northwestern Medicine First in Illinois to Implant New FDA-Approved Aortic Valve 111
  • 6.42 Sep 27, 2016: Artificial Blood Vessels Developed in the Lab can Grow with the Recipient 112
  • 6.43 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 113

7 Appendix 115

  • 7.1 Methodology 115
  • 7.2 About GlobalData 118
  • 7.3 Contact Us 118
  • 7.4 Disclaimer 118

List of Tables

1.1 List of Tables

  • Table 1: Tissue Heart Valves - Pipeline Products by Stage of Development 8
  • Table 2: Tissue Heart Valves - Pipeline Products by Segment 9
  • Table 3: Tissue Heart Valves - Pipeline Products by Territory 10
  • Table 4: Tissue Heart Valves - Pipeline Products by Regulatory Path 11
  • Table 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date 12
  • Table 6: Tissue Heart Valves - Ongoing Clinical Trials 13
  • Table 7: Tissue Heart Valves Companies - Pipeline Products by Stage of Development 14
  • Table 8: Tissue Heart Valves - Pipeline Products by Stage of Development 15
  • Table 9: Abbott Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview 16
  • Table 10: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Status 16
  • Table 11: Tendyne Bioprosthetic Mitral Valve Implantation System - Product Description 16
  • Table 12: Abbott Vascular Inc - Ongoing Clinical Trials Overview 17
  • Table 13: Tendyne Bioprosthetic Mitral Valve Implantation System - Early Feasibility Study of the Tendyne Mitral Valve System 18
  • Table 14: Tendyne Bioprosthetic Mitral Valve Implantation System - Safety and Performance of the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) in Inoperable Subjects with Mitral Regurgitation (MR) 18
  • Table 15: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview 19
  • Table 16: Heart Valve Leaflet - Product Status 19
  • Table 17: Heart Valve Leaflet - Product Description 19
  • Table 18: Colibri Heart Valve, LLC Pipeline Products & Ongoing Clinical Trials Overview 20
  • Table 19: Pulmonary Valve - Product Status 20
  • Table 20: Pulmonary Valve - Product Description 20
  • Table 21: Sutureless Surgical Aortic Valve - Product Status 21
  • Table 22: Sutureless Surgical Aortic Valve - Product Description 21
  • Table 23: CorMatrix Cardiovascular Inc Pipeline Products & Ongoing Clinical Trials Overview 22
  • Table 24: CorMatrix ECM - Heart Valve Repair - Product Status 22
  • Table 25: CorMatrix ECM - Heart Valve Repair - Product Description 22
  • Table 26: CorMatrix ECM - Heart Valve Replacement - Product Status 23
  • Table 27: CorMatrix ECM - Heart Valve Replacement - Product Description 23
  • Table 28: CorMatrix ECM Tricuspid Heart Valve - Product Status 23
  • Table 29: CorMatrix ECM Tricuspid Heart Valve - Product Description 24
  • Table 30: CorMatrix Cardiovascular Inc - Ongoing Clinical Trials Overview 25
  • Table 31: CorMatrix ECM - Heart Valve Repair - Cardial Infarct Repair Using CorMatrix-ECM: Clinical Feasibility Study 26
  • Table 32: CorMatrix ECM Tricuspid Heart Valve - CorMatrix ECM Tricuspid Valve Replacement Safety and Early Feasibility 27
  • Table 33: CryoLife Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 34: CryoValve SGAV - Product Status 28
  • Table 35: CryoValve SGAV - Product Description 28
  • Table 36: Synergraft Xenograft Heart Valve - Product Status 29
  • Table 37: Synergraft Xenograft Heart Valve - Product Description 29
  • Table 38: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
  • Table 39: Cytograft Valve - Product Status 30
  • Table 40: Cytograft Valve - Product Description 30
  • Table 41: Daidalos Solutions BV Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 42: Sutureless Aortic valve Prosthesis - Product Status 31
  • Table 43: Sutureless Aortic valve Prosthesis - Product Description 31
  • Table 44: Sutureless Mitral Valve Prostheses - Product Status 32
  • Table 45: Sutureless Mitral Valve Prostheses - Product Description 32
  • Table 46: Sutureless Tricuspid Valve Prostheses - Product Status 32
  • Table 47: Sutureless Tricuspid Valve Prostheses - Product Description 33
  • Table 48: Edwards Lifesciences Corp Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 49: GLX Aortic Conduit - Product Status 34
  • Table 50: GLX Aortic Conduit - Product Description 35
  • Table 51: INSPIRIS RESILIA Aortic Valve - Product Status 35
  • Table 52: INSPIRIS RESILIA Aortic Valve - Product Description 35
  • Table 53: INTUITY Valve System - Product Status 36
  • Table 54: INTUITY Valve System - Product Description 36
  • Table 55: KONECT Conduit - Product Status 36
  • Table 56: KONECT Conduit - Product Description 37
  • Table 57: Magna EASE Surgical Valve With GLX - Product Status 37
  • Table 58: Magna EASE Surgical Valve With GLX - Product Description 37
  • Table 59: Edwards Lifesciences Corp - Ongoing Clinical Trials Overview 38
  • Table 60: INTUITY Valve System - A Randomized Comparison of the EDWARDS INTUITY Valve System and Commercially Available Aortic Bioprostheses in Subjects Undergoing Surgical Aortic Valve Replacement 39
  • Table 61: INTUITY Valve System - Multi-center Experience with the Rapid Deployment Edwards INTUITY Valve System for Aortic Valve Replacement 39
  • Table 62: INTUITY Valve System - Surgical Treatment of Aortic Stenosis with a Next Generation Surgical Aortic Valve 39
  • Table 63: Magna EASE Surgical Valve With GLX - Clinical Study to Evaluate the Performance of Magna Ease Heart Valve in Chinese Patients 40
  • Table 64: Magna EASE Surgical Valve With GLX - Edwards Receives IDE for U.S. Clinical Trial of New Heart Valve Tissue Treatment Platform 40
  • Table 65: INSPIRIS RESILIA Aortic Valve - Prospective, Non-randomized, Multicenter Clinical Evaluation of the Edwards Pericardial Aortic and Mitral Bioprostheses (Models 11000a and 11000m) with a New Tissue Treatment Platform: COMMENCE 41
  • Table 66: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 67: Avalus Surgical Aortic Valve - Product Status 42
  • Table 68: Avalus Surgical Aortic Valve - Product Description 42
  • Table 69: Closed-Chest Aortic Tissue Valve - Product Status 43
  • Table 70: Closed-Chest Aortic Tissue Valve - Product Description 43
  • Table 71: Enable Valve-Beating Heart Procedure - Product Status 43
  • Table 72: Enable Valve-Beating Heart Procedure - Product Description 43
  • Table 73: Medtronic plc - Ongoing Clinical Trials Overview 44
  • Table 74: Avalus Surgical Aortic Valve - Medtronic Pericardial Surgical Aortic Valve Replacement Pivotal Trial a Multi-center, Non-randomized Trial to Determine the Safety and Effectiveness of the Model 400 Aortic Valve Bioprosthesis in Patients with Aortic Valve Disease 45
  • Table 75: Revivicor Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 76: Heart Valve - Product Status 46
  • Table 77: Heart Valve - Product Description 46
  • Table 78: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 79: Tissue Based Cardiac Valve - Product Status 47
  • Table 80: Tissue Based Cardiac Valve - Product Description 47
  • Table 81: Stellenbosch University Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 82: Percutaneous Heart Valve - Product Status 48
  • Table 83: Percutaneous Heart Valve - Product Description 48
  • Table 84: Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 85: Cardiopure - Aortic Heart Valve - Product Status 49
  • Table 86: Cardiopure - Aortic Heart Valve - Product Description 49
  • Table 87: Cardiopure - Pulmonary Heart Valve - Product Status 50
  • Table 88: Cardiopure - Pulmonary Heart Valve - Product Description 50
  • Table 89: CardioPure HV - Product Status 50
  • Table 90: CardioPure HV - Product Description 51
  • Table 91: University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 52
  • Table 92: Bileaflet Bioprosthetic Mitral Valve - Product Status 52
  • Table 93: Bileaflet Bioprosthetic Mitral Valve - Product Description 52
  • Table 94: Heart Valve Leaflets - Product Status 53
  • Table 95: Heart Valve Leaflets - Product Description 53
  • Table 96: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 97: Polymeric Heart Valve - Product Status 54
  • Table 98: Polymeric Heart Valve - Product Description 54
  • Table 99: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 100: Tissue-Engineered Vessel Graft - Product Status 55
  • Table 101: Tissue-Engineered Vessel Graft - Product Description 55
  • Table 102: ValveXchange, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 103: Vanguard System - Product Status 56
  • Table 104: Vanguard System - Product Description 56
  • Table 105: Vitality Exchangeable Valve System - Product Status 57
  • Table 106: Vitality Exchangeable Valve System - Product Description 57
  • Table 107: VXi Vanguard II - Product Status 57
  • Table 108: VXi Vanguard II - Product Description 58
  • Table 109: VueKlar Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 110: MR-Enhancing Percutaneous Heart Valve - Product Status 59
  • Table 111: MR-Enhancing Percutaneous Heart Valve - Product Description 59
  • Table 112: Glossary 117

List of Figures

1.2 List of Figures

  • Figure 1: Tissue Heart Valves - Pipeline Products by Stage of Development 8
  • Figure 2: Tissue Heart Valves - Pipeline Products by Segment 9
  • Figure 3: Tissue Heart Valves - Pipeline Products by Territory 10
  • Figure 4: Tissue Heart Valves - Pipeline Products by Regulatory Path 11
  • Figure 5: Tissue Heart Valves - Pipeline Products by Estimated Approval Date 12
  • Figure 6: Tissue Heart Valves - Ongoing Clinical Trials 13
Back to Top